✦ LIBER ✦

P-331 For richer, for poorer: A willingness-to-pay study of oral epidermal growth factor tyrosine kinase inhibitors in advanced non-small cell lung cancer

✍ Scribed by Leighl, N.; Tsao, S.; Zawisza, D.; Nematollahi, M.; Shepherd, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A willingness-to-pay study of oral epide

✍ Leighl, Natasha B.; Tsao, W. Stephen; Zawisza, Dianne L.; Nematollahi, Mahsan; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Mechanisms of Acquired Resistance to Epi

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

A review of small-molecule epidermal gro

✍ Katrina Y Glover; Roman Perez-Soler; Vassiliki A Papadimitradopoulou 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Epidermal Growth Factor Receptor Tyrosin

✍ Jamal-Hanjani, M.; Spicer, J. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 320 KB

Oral epidermal growth factor receptor ty

✍ Peters, Solange; Zimmermann, Stefan; Adjei, Alex A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Erlotinib (OSI-774, Tarceva™), a Selecti

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB